Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I
Department of Neurology, University Hospital, Jihlavská 20, 63900 Brno, Czech Republic.
J Neurol. 2005 Mar;252(3):343-51. doi: 10.1007/s00415-005-0654-x. Epub 2005 Mar 30.
Although numerous clinical, laboratory, and pharmacological variables have been reported as significant risk factors for critical illness polyneuromyopathy (CIPM), there is still no consensus on the aetiology of this condition. Objectives of the study were to assess the clinical and electrophysiological incidence and risk factors for CIPM.A cohort of critically ill patients was observed prospectively for a one-month period and the association between neuromuscular involvement and various potential risk factors was evaluated. Sixty one critically ill patients completed the follow-up (30 women, 31 men, median age 59 years).CIPM development was detected clinically in 17 patients (27.9 %) and electrophysiologically in 35 patients (57.4 %). CIPM was significantly associated with the presence and duration of systemic inflammatory response syndrome and the severity of multiple, respiratory, central nervous, and cardiovascular organ failures. The median duration of mechanical ventilation was significantly longer in patients with CIPM than in those without (16 vs 3 days, p<0.001). Independent predictors of CIPM obtainable within the 1(st) week of critical illness were the admission sequential organ failure assessment score (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.02-1.36), the 1(st) week total sequential organ failure assessment scores (OR, 1.14; 95 % CI, 1.06-1.46) and the 1(st) week duration of systemic inflammatory response syndrome (OR, 1.05; 95% CI, 1.01-1.15). They were able to correctly predict the development of CIPM at the end of the 1(st) week in about 80% of critically ill cases.In conclusion, the presence and duration of systemic inflammatory response syndrome and the severity of multiple and several organ failures are associated with increased risk of the development of CIPM.
尽管已有众多临床、实验室及药理学变量被报道为危重病性多神经肌病(CIPM)的重要危险因素,但对于该病症的病因仍未达成共识。本研究的目的是评估CIPM的临床及电生理发病率和危险因素。对一组危重病患者进行了为期1个月的前瞻性观察,并评估了神经肌肉受累与各种潜在危险因素之间的关联。61例危重病患者完成了随访(30名女性,31名男性,中位年龄59岁)。17例患者(27.9%)临床检测到CIPM发展,35例患者(57.4%)电生理检测到CIPM发展。CIPM与全身炎症反应综合征的存在和持续时间以及多器官、呼吸、中枢神经和心血管器官功能衰竭的严重程度显著相关。CIPM患者的机械通气中位持续时间显著长于无CIPM患者(16天对3天,p<0.001)。危重病第1周内可获得的CIPM独立预测因素为入院序贯器官衰竭评估评分(比值比[OR],1.15;95%置信区间[CI],1.02 - 1.36)、第1周序贯器官衰竭评估总分(OR,1.14;95% CI,1.06 - 1.46)以及第1周身炎症反应综合征持续时间(OR,1.05;95% CI,1.01 - 1.15)。它们能够在约80%的危重病病例中正确预测第1周结束时CIPM的发展。总之,全身炎症反应综合征的存在和持续时间以及多器官和多个器官功能衰竭的严重程度与CIPM发生风险增加相关。